← Leaderboards
Wilson Gonsalves
Mayo Clinic Rochester
$2,016,449
Attributed
$2,016,449
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $430.9K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,016,449 · 2
By mechanism
R01$1,503,881 · 1
K23$512,568 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Shaji Kunnathu Kumar$7,127,192
- Ian R Lanza$12,553,585
- Cornelia M Weyand$30,789,284
- Matthew T Drake$1,143,985
- Louis James Maher$21,515,136
Others in their field
Other Emerging Leaders on “Prevention Strategy”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$54,053,670
- Mark Marino · Venturewell$48,913,644
- Olwen Hahn · Brigham And Women'S Hospital$31,632,321
- Bryan Faller · Decatur Memorial Hospital$29,346,991
Research focus
Prevention StrategyResearch ProposalsPlasma CellsPremalignantMetabolomicsMultiple MyelomaMemberPlasmaExperimental StudyMetabolic PathwayMalignant NeoplasmsBone MarrowMonoclonal GammapathiesMonoclonal Gammopathy Of Uncertain SignificanceBiobankC-Myc GenesMass Spectrum AnalysisPathogenesisCessation Of LifeBiological MarkersMetabolicEnsureClinicResources
Grant awards (8)
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies$345,528
R01 · FY2024 · CA · contact PI
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies$356,438
R01 · FY2023 · CA · contact PI
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies$74,489
R01 · FY2023 · CA · contact PI
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies$363,713
R01 · FY2022 · CA · contact PI
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies$363,713
R01 · FY2021 · CA · contact PI
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma$170,856
K23 · FY2019 · CA · contact PI
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma$170,856
K23 · FY2018 · CA · contact PI
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma$170,856
K23 · FY2017 · CA · contact PI